News - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News


Pharmaceutical Technology Europe
Volume 23, Issue 11

News bites

EMA invites feedback
The EMA released two concept papers for a 3month public consultation that address the need to revise existing guidelines on biosimilar medicines and influenza vaccines. Feedback can be submitted until 31 December 2011.

Read more at: http://www.pharmtech.com/EMApapers

AstraZeneca in China
AstraZeneca is investing $200 million in a new manufacturing facility in China for intravenous and solid medicines. The facility will be located in Taizhou, with construction due to finish at the end of 2013, and will help the company to expand its medicines availability in urban and rural communities.

Read more at: http://www.pharmtech.com/azinchina

GSK and fast cars
GSK has formed a long-term partnership with the UK-based McLaren Group, which is best known for its expertise in the Formula 1 motor sport. McLaren will share its capabilities in engineering, technology, analytics and strategy modelling to help improve GSK's manufacturing, R&D and consumer-healthcare areas.

Read more at: http://www.pharmtech.com/formula1

FDA enhances database
The FDA is considering whether to enhance its inspections database by adding specific search criteria that would both enhance data analysis and make the system more user friendly. The idea was included in a list of eight draft proposals for increasing transparency that the agency published in October.

Read more at: http://www.pharmtech.com/fdasearch

Sign up for our weekly e-Alert at http://www.pharmtech.com/signup


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology Europe,
Click here